Evidence map›Paper›PMID 34660918›Full record

ArticleeNeurologicalSci2021

Hashimoto's encephalopathy with gait disturbance caused by sensory ganglionopathy: A case report and review of the literature.

Tomoyo Shimada, Sho Nakajima, Ryota Nakamura, Naohide Kurita, Kotaro Ogaki, Masao Watanabe, Kazuo Yamashiro, Takao Urabe

Open access · goldAbstract read
In one paragraph

Article in eNeurologicalSci, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tomoyo ShimadaDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Sho NakajimaDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Ryota NakamuraDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Naohide KuritaDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Kotaro OgakiDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Masao WatanabeDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Kazuo YamashiroDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Takao UrabeDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Juntendo University Urayasu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hashimoto's encephalopathy (HE) is a steroid-responsive encephalopathy characterized by several neurological symptoms. HE mainly involves the central nervous system; the peripheral nervous system is rarely involved. We treated a previously healthy elderly man showing mild cognitive decline and subacute progressive gait disturbance due to severe sensory deficits, including sensation of touch and deep sensation with elevated anti-NH2 terminal of α-enolase and anti-thyroid antibodies. His sensory disturbance symptoms improved after steroid therapy, suggesting that the neuropathy was related to HE. His disease was characteristic of HE in that his sensory deficits responded well and rapidly to steroid therapy. A nerve conduction study showed reduced sensory nerve action potentials in all limbs, indicating that his neuropathy was not "axonopathy", but "sensory ganglionopathy", which can occur concurrently with autoimmune disorders. Dysautonomia may be the responsible pathomechanism because of the vulnerability of the blood-nerve barrier at the ganglia. Although the pathophysiology of HE has not been clearly elucidated, autoimmune inflammation has been reported in a number of autopsy cases, indicating that sensory ganglionopathy can develop with HE. Therefore, HE should be recognized as one type of "treatable neuropathy".

Indexed as

GanglionopathyHashimoto's encephalopathyPeripheral neuropathySensory neuropathySteroid therapy

Identifiers

PMID34660918
PMCPMC8502713
OpenAlexW3204300702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.